Skip to main content

members mark mini nicotine

NDC 68196-957 · Sam's West Inc

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

68196-957-07 — 8 CONTAINER in 1 CARTON (68196-957-07) / 27 LOZENGE in 1 CONTAINER (68196-957-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68196-029 — Nicotine Polacrilex, 68196-082 — Nicotine Polacrilex, 68196-084 — Nicotine Polacrilex, 68196-170 — Nicotine Polacrilex, 68196-194 — nicotine, 68196-269 — nicotine polacrilex, 68196-309 — Nicotine Polacrilex, 68196-734 — Nicotine Polacrilex, 68196-811 — nicotine polacrilex, 68196-873 — Nicotine Polacrilex, 68196-971 — nicotine polacrilex, 68391-012 — Nicotine polacrilex, 68391-029 — Nicotine Polacrilex, 68391-170 — Nicotine Polacrilex, 68391-309 — Nicotine Polacrilex, 68391-344 — Nicotine Polacrilex, 68391-734 — Nicotine Polacrilex, 68391-873 — Nicotine Polacrilex, 68391-957 — Nicotine Polacrilex, 69842-024 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels